Concepedia

Hasna Bouchaab

HB

Statistics

Publications

24

Citations

1K

H-Index

15

Active since

2014

Affiliations

University of Lausanne(Current)

University Hospital of Lausanne

Ludwig Cancer Research

University Hospital of Basel

Kantonsspital Winterthur

Hasna Bouchaab is an author at University of Lausanne specializing in oncology, medicine, and immunology.

ORCID

Publications per year

2014–2024

24

Publications

24

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

Eleonora Ghisoni, Alexandre Wicky, Hasna Bouchaab et al. · European Journal of Cancer · 2021 · 186 citations · Full text

, , +16

ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer

Antonio Passaro, Alfredo Addeo, Christophe von Garnier et al. · ESMO Open · 2020 · 132 citations · Full text

, , +14

Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma

Yannis Metaxas, Gareth Rivalland, Laetitia Mauti et al. · Journal of Thoracic Oncology · 2018 · 91 citations · Full text

, , +14

A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy

Florian Huber, Marion Arnaud, Brian J. Stevenson et al. · Nature Biotechnology · 2024 · 86 citations · Full text

, , +17

<sup>68</sup>Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis

Sarah Boughdad, Sofiya Latifyan, Craig Fenwick et al. · Journal for ImmunoTherapy of Cancer · 2021 · 77 citations · Full text

, , +17

1–5 of 24